Informatics

AI Cardiac Arrest Prediction – Review
Tech & Innovation AI Cardiac Arrest Prediction – Review

The difference between survival and fatality in sudden cardiac arrest (SCA) is often measured in seconds, yet the medical community has historically lacked the tools to see the storm gathering before it breaks. For decades, the unpredictability of SCA has been its most lethal characteristic,

Can Asia-Pacific Nations Close the Rare Disease Care Gap?
Tech & Innovation Can Asia-Pacific Nations Close the Rare Disease Care Gap?

Across the vast and diverse landscapes of the Asia-Pacific region, millions of individuals living with rare diseases have long faced a silent struggle characterized by delayed diagnoses and limited medical resources. The recent establishment of the HGP2 Rare Disease Alliance of the Asia-Pacific

Can AI Map Tumor Genetics From Standard Biopsy Slides?
Tech & Innovation Can AI Map Tumor Genetics From Standard Biopsy Slides?

A microscopic glass slide containing a thin slice of tumor tissue has traditionally served as a static window for pathologists to observe cellular abnormalities through the lens of a high-powered microscope. These seemingly simple images are now being reinterpreted as dense reservoirs of biological

Can Step-by-Step AI Reasoning Improve Diagnostic Accuracy?
Tech & Innovation Can Step-by-Step AI Reasoning Improve Diagnostic Accuracy?

The rapid evolution of large language models has fundamentally transformed clinical decision support by moving beyond simple automated suggestions toward complex, reasoned interactions that mirror human cognitive processes. In modern medical practice, clinicians often face the daunting task of

Can AI Personalize Treatments for Parkinson’s Disease?
Tech & Innovation Can AI Personalize Treatments for Parkinson’s Disease?

Ivan Kairatov is a leading figure in the biopharmaceutical sector, renowned for his ability to navigate the complex intersection of high-tech innovation and clinical development. With a career rooted in deep-tier research and development, Kairatov has spent years dissecting how molecular

How Will NYU’s $70 Million NIH Grant Advance Patient Care?
Tech & Innovation How Will NYU’s $70 Million NIH Grant Advance Patient Care?

Ivan Kairatov stands as a prominent figure in the biopharmaceutical sector, bringing decades of insight into how technological innovation and rigorous research and development intersect to redefine modern medicine. With a career rooted in bridging the gap between molecular discovery and clinical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later